# Evaluation of the Clinical Impact of Adjunctive L-carnitine Therapy in Critically Ill Hepatic Patients Admitted to Intensive Care Unit

> **NCT07642076** · PHASE4 · RECRUITING · sponsor: **Beni-Suef University** · enrollment: 58 (estimated)

## Conditions studied

- Hepatic

## Interventions

- **DRUG:** L Carnitine
- **DRUG:** Standard medical treatment

## Key facts

- **NCT ID:** NCT07642076
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-15
- **Primary completion:** 2026-12
- **Final completion:** 2027-03
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2026-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07642076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07642076, "Evaluation of the Clinical Impact of Adjunctive L-carnitine Therapy in Critically Ill Hepatic Patients Admitted to Intensive Care Unit". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07642076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
